Related Experiment Video
Updated: Sep 26, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
Farhoud Faraji1,2,3, Sydney I Ramirez3,4, Paola Y Anguiano Quiroz5
1Department of Otolaryngology-Head and Neck Surgery, University of California San Diego Health, La Jolla, CA 92093, USA.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) represents a highly prevalent and deadly malignancy worldwide. The prognosis for locoregionally advanced HNSCC has not appreciably improved over the past 30 years despite advances in surgical, radiation, and targeted therapies and less than 20% of HNSCC patients respond to recently approved immune checkpoint inhibitors. The Hippo signaling pathway, originally discovered as a mechanism regulating tissue growth and organ size, transduces intracellular and extracellular signals to regulate the transcriptional co-activators YAP and TAZ. Alterations in the Hippo pathway resulting in persistent YAP and TAZ activation have emerged as major oncogenic drivers. Our analysis of the human HNSCC oncogenome revealed multiple genomic alterations impairing Hippo signaling and activating YAP and TAZ, which in turn contribute to HNSCC development. This includes mutations and deletions of the FAT1 gene (29%) and amplification of the WWTR1 (encoding TAZ, 14%) and YAP1 genes (8%), together representing one of the most genetically altered signaling mechanisms in this malignancy. Here, we discuss key elements of the mammalian Hippo pathway, detail mechanisms by which perturbations in Hippo signaling promote HNSCC initiation and progression and outline emerging strategies to target Hippo signaling vulnerabilities as part of novel multimodal precision therapies for HNSCC.
Insights
Head and neck squamous cell carcinoma (HNSCC) is a deadly cancer. Hippo pathway alterations, including FAT1, WWTR1, and YAP1 gene changes, drive HNSCC development and offer new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Head and neck squamous cell carcinoma (HNSCC) remains a prevalent and lethal malignancy with limited therapeutic advancements.
- Despite progress in surgery, radiation, and targeted treatments, prognosis for advanced HNSCC has stagnated, with poor response rates to immune checkpoint inhibitors.
Purpose of the Study:
- To investigate the role of the Hippo signaling pathway in HNSCC development.
- To identify specific genetic alterations within the Hippo pathway that contribute to HNSCC oncogenesis.
- To explore potential therapeutic strategies targeting Hippo pathway vulnerabilities in HNSCC.
Main Methods:
- Analysis of the human HNSCC oncogenome to identify genetic alterations.
- Examination of mutations, deletions, and amplifications in key Hippo pathway genes (FAT1, WWTR1, YAP1).
- Review of existing literature on Hippo pathway function and its role in cancer.
Main Results:
- Genomic alterations impairing Hippo signaling and activating YAP/TAZ were identified in HNSCC.
- FAT1 gene alterations (mutations/deletions) occurred in 29% of cases.
- WWTR1 (TAZ) and YAP1 gene amplifications were observed in 14% and 8% of cases, respectively.
Conclusions:
- Aberrant Hippo signaling, driven by genetic alterations in FAT1, WWTR1, and YAP1, is a significant oncogenic mechanism in HNSCC.
- These findings highlight the Hippo pathway as a critical player in HNSCC initiation and progression.
- Targeting Hippo pathway vulnerabilities presents a promising avenue for developing novel precision therapies for HNSCC.
More Related Videos
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...